A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis

Abroad (travel likely)RecruitingPHASE1

Conditions

Secondary AML · Myelofibrosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

City of Hope Center, Duarte, California, United States
Contact: Study coordinator (Haris Ali, MD) · harisali@coh.org · 626-218-2405
Contact: Study coordinator (Farrah Farshidfard) · ffarshidfard@coh.org · 626-218-2918
Contact: Principal Investigator (Haris Ali, MD)
UC Davis Comprehensive Cancer Center, Sacramento, California, United States
Contact: Study coordinator (OCR Referral Team Team) · OCRReferral@health.ucdavis.edu · 916-382-6970
Contact: Principal Investigator (Brian Jonas, MD)
UC San Diego Moores Cancer Center, San Diego, California, United States
Contact: Study coordinator (Rebecca Jimenez, MD, PhD) · rejimenez@health.ucsd.edu · 858-822-5377
Contact: Study coordinator (Oliva Nolan) · ocnolan@health.ucsd.edu · 858-246-5794
Contact: Principal Investigator (James Mangan, MD)

Study leads

James Mangan, MD, PhD
Principal Investigator
UC San Diego Moores Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Hematologic Malignancy · Bone Marrow Transplant Rejection · Acute Myeloid Leukemia (AML)

Abroad (travel likely)RecruitingEARLY_PHASE1

Baltimore, United States

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

Acute Myeloid Leukemia · Essential Thrombocythemia · Myelodysplastic Syndrome

Abroad (travel likely)RecruitingPHASE2

Seattle, United States

The Patient Cohort of the National Center for Precision Medicine in Leukemia

Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia · High-risk Myelodysplastic Syndrome

Abroad (travel likely)Recruiting

Bobigny, France · Paris, France